Order results by:
Issue | Title | |
Vol 7, No 3 (2011) | COSTS OF THE HEALTH CARE IN RUSSIA ASSOCIATED WITH SMOKING | Abstract similar documents |
A. V. Kontsevaya, A. M. Kalinina | ||
"... total costs of the health care system associated with smoking exceeded RUR 35.8 bln. It corresponded ..." | ||
Vol 14, No 1 (2018) | SMOKING AS A RISK FACTOR FOR CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 2. Advantages of quitting smoking. Strategies to quit smoking | Abstract similar documents |
O. D. Ostroumova, I. I. Kopchjonov, T. F. Guseva | ||
"... who continue to smoke. Smoking cessation is the most cost-effective strategy of cardiovascular disease ..." | ||
Vol 8, No 3 (2012) | PHARMACOECONOMIC ASPECTS OF NICOTINE ADDICTION TREATMENT IN PATIENTS WITH ANGINA REQUIRING CARDIAC SURGERY | Abstract similar documents |
A. V. Rudakova, M. S. Berezhnova | ||
"... Smoking is a major risk factor in patients with angina pectoris. Interventions that facilitate ..." | ||
Vol 1, No 1 (2005) | DRUGS AND SMOKING | Abstract similar documents |
J. V. Lukina | ||
"... Smoking is a well – known risk factor of many diseases. It influences the efficacy and safety ..." | ||
Vol 13, No 6 (2017) | SMOKING AS A RISK FACTOR OF CARDIOVASCULAR AND CEREBROVASCULAR DISEASES: PREVALENCE, IMPACT ON PROGNOSIS, POSSIBLE SMOKING CESSATION STRATEGIES AND THEIR EFFECTIVENESS. Part 1. Smoking Prevalence and Impact on Prognosis | Abstract similar documents |
O. D. Ostroumova, A. A. Izvekov, N. Yu. Voevodina | ||
"... The prevalence of smoking in the Russian Federation is 27.7%. Losses of potential years of life ..." | ||
Vol 15, No 1 (2019) | Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation | Abstract similar documents |
S. R. Gilyarevskiy | ||
"... Modern problems caused by the high prevalence of smoking, as well as pharmacological approaches ..." | ||
Vol 17, No 4 (2021) | Association of smoking with indicators of the structure and function of left ventricle of the heart in middle-aged men | Abstract PDF (Eng) similar documents |
O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, M. B. Kotova, M. A. Isaykina, O. M. Drapkina | ||
"... Aim. Evaluation of the association of smoking (status, intensity and duration) with indicators ..." | ||
Vol 16, No 6 (2020) | Association of Smoking with Indicators of the Structure and Function of Blood Vessels in Middle-aged Men | Abstract similar documents |
O. Yu. Isaykina, V. B. Rozanov, А. А. Aleksandrov, M. B. Kotova | ||
"... Aim. To study the association of smoking with indicators of the structure and function of blood ..." | ||
Vol 15, No 4 (2019) | The Association of Smoking Status and Intensity of Smoking with Blood Lipid Spectrum in a Sample of Middle-Aged Men | Abstract similar documents |
A. A. Alexandrov, V. B. Rozanov, M. B. Kotova, V. A. Dadaeva, E. I. Ivanova | ||
"... on a standard questionnaire (passport data, the presence of bad habits [smoking, alcohol consumption]), a three ..." | ||
Vol 9, No 3 (2013) | NICOTINE REPLACEMENT THERAPY OF THE TOBACCO ADDICTION IN PREVENTION OF CARDIORESPIRATORY DISEASES | Abstract similar documents |
M. G. Gambaryan | ||
"... of cardiorespiratory diseases. Smoking cessation is the most cost-effective measure for prevention of cardiovascular ..." | ||
Vol 7, No 4 (2011) | METHODS OF ASSISTANCE FOR SMOKING CESSATION IN INTERNATIONAL CLINICAL RECOMMENDATIONS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASE | Abstract similar documents |
M. S. Berezhnova | ||
"... A review of international recommendations, including methods to assist in smoking cessation ..." | ||
Vol 9, No 4 (2013) | VARENICLINE IN PATIENTS WITH CARDIOVASCULAR DISEASES – FRIEND OR ENEMY? | Abstract similar documents |
Yu. V. Lukina, S. Yu. Martsevich | ||
"... for pharmacotherapy of nicotine addiction due to its high efficacy and advantages of smoking cessation. However ..." | ||
Vol 15, No 3 (2019) | The Prevalence of Smoking in 41-43-Year-Old Males and its Relation to Some Risk Factors | Abstract PDF (Eng) similar documents |
A. A. Alexandrov, M. V. Kotova, E. I. Ivanova, V. B. Rozanov | ||
"... Aim. To evaluate the prevalence of smoking in 41-43-year-old men living in Moscow and its ..." | ||
Vol 12, No 4 (2016) | The implementation of health care aimed at the cessation of tobacco use, treatment of tobacco dependence and consequences of tobacco consumption in the Russian Federation | Abstract similar documents |
S. A. Boytsov, P. K. Yablonskiy, M. G. Gambaryan, O. A. Sukhovskaya, O. M. Drapkina | ||
Vol 17, No 4 (2021) | E-cigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease | Abstract PDF (Eng) similar documents |
V. I. Podzolkov, A. E. Bragina, N. A. Druzhinina, L. N. Mohammadi | ||
"... smoking on markers of vascular wall damage: high sensitivity C-reactive protein (hsCRP), albuminuria (AU ..." | ||
Vol 1, No 1 (2005) | TOBACCO DEPENDENCE TREATMENT WITH NICOTINE REPLACEMENT THERAPY AS ONE OF THE METHODS FOR CARDIOVASCULAR DISEASE RISK REDUCTION | Abstract similar documents |
O. V. Vikhireva, S. A. Shalnova, A. D. Deev | ||
"... to quit smoking. To assess expected reduction of cardiovascular disease (CVD) and total mortality relative ..." | ||
Vol 7, No 5 (2011) | ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
Yu. B. Belousov, I. S. Yavelov, D. Yu. Belousov, E. V. Afanasieva | ||
"... .98 RUR (in the consequent years), respectively. Conclusion. The cost of warfarin, regardless of the INR ..." | ||
Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY | Abstract similar documents |
V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
"... as patient’s compliance to the mono- or combined valsartan based therapy in smoking vs non-smoking ..." | ||
Vol 14, No 3 (2018) | ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION | Abstract similar documents |
A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, M. B. Khudyakov, O. I. Karpov, O. M. Drapkina | ||
"... required in higher expenditures (outpatients cost treatment expenditures were 2.43 billion RUR, in-patients ..." | ||
Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
"... in 2016, including direct costs of the health care system and indirect economic losses due to premature ..." | ||
Vol 9, No 3 (2013) | ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING | Abstract similar documents |
N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova | ||
"... is the most economical variant of pharmacotherapy due to low cost of treatment (16.491.25 RUR per 1 QALY ..." | ||
Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
V. A. Sergeeva | ||
"... , smoking, physical inactivity) were present. Lipid-lowering drugs were regularly taken by 26 ..." | ||
Vol 14, No 4 (2018) | Association of Conventional Cardiovascular Risk Factors with Carotid Atherosclerosis Prevalence in General Population | Abstract similar documents |
V. S. Kaveshnikov, V. N. Serebryakova, I. A. Trubacheva, S. A. Shalnova | ||
"... studied: age, gender, smoking, low and high density lipoproteins (LDL-C and HDL-C), triglycerides ..." | ||
Vol 19, No 5 (2023) | White coat effect in patients with hypertension | Abstract similar documents |
G. F. Andreeva, V. M. Gorbunov, D. N. Antipushina, E. V. Platonova | ||
"... to additional prescription of antihypertensive drugs, increasing costs and side effects. To identify WCE ..." | ||
Vol 5, No 5 (2009) | THE COMPARATIVE COST-EFFICACY ANALYSIS OF VARIOUS ANTIHYPERTENSIVE THERAPIES | Abstract similar documents |
S. V. Malchikova, E. I. Tarlovskaya | ||
"... Aim. To perform the comparative cost-efficacy analysis of various antihypertensive therapies ..." | ||
Vol 7, No 2 (2011) | COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE | Abstract similar documents |
V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko | ||
"... Aim. To evaluate clinical and cost effectiveness of different reperfusion strategies in myocardial ..." | ||
Vol 16, No 6 (2020) | Chronic Kidney Disease: Current State of the Problem | Abstract similar documents |
M. M. Batiushin | ||
"... and progression of CKD. Currently, Smoking, alcohol, and physical inactivity have been shown to have a harmful ..." | ||
Vol 7, No 2 (2011) | SOCIO-ECONOMIC DAMAGE BY ACUTE CORONARY SYNDROME IN RUSSIAN FEDERATION | Abstract similar documents |
A. V. Kontsevaya, A. M. Kalinina, I. E. Koltunov, R. G. Oganov | ||
"... . Material and Methods. Direct costs and economic losses associated with ACS were estimated. The structure ..." | ||
Vol 7, No 4 (2011) | VALUE OF THERAPEUTIC EQUIVALENCE IN SUBSTITUTION OF ORIGINAL DRUG WITH GENERIC BY EXAMPLE OF FOSINIPRIL | Abstract similar documents |
N. P. Kutishenko, S. Yu. Martsevich, Zh. D. Kobalava, E. K. Shavarova | ||
"... with arterial hypertension (HT) of 1-2 degrees, and to evaluate the cost effectiveness of original drug ..." | ||
Vol 11, No 5 (2015) | Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism | Abstract similar documents |
A. V. Rudakova | ||
"... Aim. To assess the cost-effectiveness of apixaban in the treatment and secondary prevention ..." | ||
Vol 8, No 1 (2012) | ANALYSIS OF COST STRUCTURE FOR PHARMACOTHERAPY OF PATIENTS WITH STABLE ANGINA (THE CASE OF CARDIOLOGY DEPARTMENT OF TVER REGIONAL CLINICAL HOSPITAL) | Abstract similar documents |
M. A. Demidova, N. N. Kirilenko | ||
"... Aim. To analyze the cost structure for pharmacotherapy of patients with stable angina (SA ..." | ||
Vol 11, No 3 (2015) | PREVALENCE OF TYPE D PERSONALITY AND ITS ASSOCIATION WITH CARDIOVASCULAR DISEASES AND THEIR RISK FACTORS ACCORDING TO THE ESSE STUDY CONDUCTED IN KEMEROVO REGION | Abstract similar documents |
A. N. Sumin, O. I. Raykh, E. V. Indukaeva, G. V. Artamonova | ||
"... ) and patients without type D personality (n=1379). Arterial hypertension, smoking, diabetes ..." | ||
Vol 7, No 5 (2011) | ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina | ||
"... 516 772.42 RUR for every 1 000 patients. It would reduce the total costs per patient during 10 years ..." | ||
Vol 11, No 3 (2015) | ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
A. V. Rudakova | ||
"... of them the cost of anticoagulation therapy was determined on the basis of the average weighted prices ..." | ||
Vol 15, No 1 (2019) | Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 | Abstract PDF (Eng) similar documents |
S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova | ||
"... in women and correlations were stronger. In particular, smoking (hazard ratio [HR] 2.25; 95% confidence ..." | ||
Vol 7, No 4 (2011) | SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS | Abstract similar documents |
E. L. Artanova, E. V. Saleeva, I. M. Sokolov, Y. G. Shvarts | ||
"... , obesity , thyroid nodular changes, smoking and amiodarone treatment. ..." | ||
Vol 6, No 5 (2010) | PHOSPHODIESTERASE-5 INHIBITORS USE IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIOVASCULAR DISEASE IN CLINICAL PRACTICE | Abstract similar documents |
M. N. Mamedov, G. G. Sharvadze, E. A. Poddubsky, A. K. Ausheva | ||
"... , hypertension, diabetes mellitus), as well as certain risk factors (smoking, alcohol abuse, physical inactivity ..." | ||
Vol 6, No 4 (2010) | CORRELATIONS OF LOW MOLECULAR WEIGHT PHENOTYPE OF APOPROTEIN(A) AND SERUM LEVEL OF LIPOPROTEIN(A) WITH MULTIFOCAL ATHEROSCLEROSIS IN PATIENTS WITH CORONARY HEART DISEASE | Abstract similar documents |
O. I. Afanasieva, M. V. Ezhov, M. I. Afanasieva, M. S. Safarova, J. V. Berestetskaya, S. N. Pokrovsky | ||
"... analysis (including sex, age, smoking status, and Lp(a) serum level) only smoking status (β=0.203, p=0 ..." | ||
Vol 7, No 6 (2011) | EXPERIENCE OF «SCHOOL OF HEALTH» AND A ROLE OF THE GENERAL PRACTITIONER IN THE STRUGGLE WITH RISK FACTORS OF ISCHEMIC HEART DISEASE | Abstract similar documents |
N. M. Nurillaeva, A. G. Gadaev | ||
"... in 14.6%, low physical activity in 7.4%, smoking in 6.6%. Conclusion. Organization of the "School ..." | ||
Vol 9, No 1 (2013) | CLINICAL AND COST EFFECTIVENESS OF PREVENTIVE COUNSELING OF YOUNG PATIENTS WITH ARTERIAL HYPERTENSION IN PRIMARY HEALTH CARE | Abstract similar documents |
M. I. Shupina, O. Ju. Korennova, E. N. Loginova | ||
"... Aim. To study clinical and cost effectiveness of training of young patients with arterial ..." | ||
Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
A. V. Rudakova, V. A. Parfenov | ||
"... in patients with NVAF in the Russian Federation. Aim. To evaluate the cost-effectiveness ratio of apixaban ..." | ||
Vol 8, No 1 (2012) | CHANGES IN THE COSTS OF HYPERTENSIVE CRISIS THERAPY DUE TO OPTIMIZATION OF DRUG SUPPLY IN THE PRE-ADMISSION CARE | Abstract similar documents |
N. I. Gaponova, N. F. Plavunov, V. L. Baratashvili | ||
"... Aim. To assess the changes in the costs of treatment of patients with hypertensive crisis (HC ..." | ||
Vol 4, No 3 (2008) | INFLUENCE OF HEALTH SCHOOL TRAINING OF PATIENTS WITH ISCHEMIC HEART DISEASE ON PHARMACOTHERAPY PROFILE AND COST (АВС/VEN ANALYSIS) | Abstract similar documents |
A. V. Kontsevaja, А. М. Kalinina, E. J. Spivak | ||
"... Aim. To study influence of patient training in Health School on pharmacotherapy profile and cost ..." | ||
Vol 6, No 4 (2010) | ECONOMIC EFFICIENCY OF THE IMPLEMENTATION OF THE PROGRAM OF CARDIOVASCULAR DISEASES MULTIFACTORIAL PREVENTION IN THE ORGANIZED COLLECTIVE OF TECHNICAL RESEARCH INSTITUTE | Abstract similar documents |
A. V. Kontsevaya, A. M. Kalinina, S. V. Belonosova, J. M. Pozdnjakov, M. B. Khudyakov | ||
"... consultation. Costs associated with cardiovascular diseases and risk factors (medical care consumption ..." | ||
Vol 9, No 4 (2013) | COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky | ||
"... Aim. To compare direct medical costs of dabigatran and warfarin therapy in patients with non ..." | ||
Vol 15, No 2 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors | Abstract similar documents |
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
"... , with breastfeeding, in menopause, and decreases during hormone replacement therapy. Smoking women have a BAC ..." | ||
Vol 17, No 3 (2021) | Changes in Cardiovascular Risk Factors in Residents of the Siberian Region (According to Epidemiological Studies) | Abstract PDF (Eng) similar documents |
G. V. Artamonova, S. A. Maksimov, D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, T. A. Mulerova, E. B. Shapovalova, A. S. Agienko, O. V. Nakhratova, O. L. Barbarash | ||
"... analyzed the prevalence of smoking, diabetes mellitus, overweight and obesity, abdominal obesity ..." | ||
Vol 13, No 6 (2017) | FACTORS INFLUENCING ON THE MORTALITY IN PATIENTS WITH OBLITERATING DISEASES OF LOWER LIMB ARTERIES | Abstract similar documents |
A. N. Sumin, M. A. Kosova, Ju. D. Medvedeva, A. V. Shcheglova, O. I. Rajh, S. A. Makarov, G. V. Artamonova, L. S. Barbarash | ||
"... frequent in patients with lethal outcome, they were characterized by a longer smoking experience (17 ..." | ||
Vol 17, No 2 (2021) | Main Factors Related with the White Coat Effect Level in Patients with Arterial Hypertension and Bronchial Asthma | Abstract similar documents |
G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Y. N. Koshelyaevskaya | ||
"... intake and smoking we identified the association with the lower WCE levels. In AH+BA patients ..." | ||
Vol 17, No 3 (2021) | The “Inverse” Seasonal Blood Pressure Variability Phenotype | Abstract similar documents |
V. M. Gorbunov, M. I. Smirnova, Y. N. Koshelyaevskaya, N. N. Panueva, N. V. Furman, P. V. Dolotovskaya | ||
"... levels of some risk factors (smoking) characterize the patients with inverse BPV. According to the HOMED ..." | ||
Vol 15, No 3 (2019) | Modern Concepts of Fibromuscular Dysplasia of the Coronary Arteries | Abstract similar documents |
E. L. Trisvetova | ||
"... , smoking, prolonged exertion of the vascular wall, and possibly female sex hormones. In the case of acute ..." | ||
Vol 20, No 5 (2024) | Prospects for the use of anti-inflammatory therapy in patients with coronary artery disease | Abstract similar documents |
N. M. Abduzhamalova, M. N. Mamedov | ||
"... . Cardiovascular disease risk factors such as dyslipidemia, hyperglycemia, smoking, hypertension and others ..." | ||
Vol 14, No 1 (2018) | ASSOCIATION OF RISK FACTORS FOR NON-COMMUNICABLE DISEASES WITH HEALTH CARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY ACCORDING TO DATA OF POPULATION STUDY IN RUSSIAN FEDERATION | Abstract similar documents |
E. I. Suvorova, S. A. Shalnova, A. V. Kontsevaya, A. D. Deev, A. V. Kapustina, Yu. A. Balanova | ||
"... of participants who call to ambulance increased among smoking men (1,41; p<0,05) and with hyperglycemia (1,38; p<0 ..." | ||
Vol 11, No 4 (2015) | EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME | Abstract similar documents |
A. V. Rudakova, N. V. Lomakin | ||
"... . To assess the cost-effectiveness of VerifyNow P2Y12 platelet reactivity testing in patients after ACS ..." | ||
Vol 15, No 5 (2019) | Costs and Evaluation of Vital and Essential Medicines for Internal Diseases Treatment, Purchased by Medical Organizations with the Funding from the System of Obligatory Medical Insurance in 2017 | Abstract similar documents |
O. M. Drapkina, A. V. Kontsevaya, M. V. Sura, R. N. Shepel, L. M. Zhamalov | ||
"... Aim. To assess the cost and importance of the vital and essential medicines for the treatment ..." | ||
Vol 13, No 4 (2017) | HEALTHCARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY IN POPULATION AGED 50-64 ACCORDING TO THE EPIDEMIOLOGICAL ESSE-RF STUDY | Abstract PDF (Eng) similar documents |
A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, A. D. Deev, A. V. Kapustina, G. A. Muromtseva, S. E. Evstifeeva, S. A. Shalnova | ||
"... with the probability of hospitalization and/or emergency call. Smoking did not increase the probability ..." | ||
Vol 19, No 2 (2023) | Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease | Abstract similar documents |
E. D. Zharkova, Yu. V. Lukina, N. P. Kutishenko, E. T. Huseynova, N. P. Zolotareva, S. Yu. Martsevich, O. M. Drapkina | ||
"... habits (smoking), moderate physical activity, lowcholesterol and low-carb diet); (2) normalization ..." | ||
Vol 10, No 1 (2014) | ASSOCIATION BETWEEN HEART RATE VARIABILITY AND COMPONENTS OF THE METABOLIC SYNDROME IN WOMEN WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
"... , hypertriglyceridemia, hypoalphalipoproteinemia and smoking were found in the correlation analysis. Patients with RA ..." | ||
Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
"... of blood pressure, cholesterol levels, smoking elimination, correction of high glucose levels and diabetes ..." | ||
Vol 15, No 3 (2019) | Features of Atrial Fibrillation in Patients with Arterial Hypertension and Extracardial Disorders | Abstract similar documents |
L. D. Khidirova, D. A. Yakhontov, S. A. Zenin, M. N. Mamedov | ||
"... assessment of risk factors (smoking and alcohol) did not show significant differences in prevalence ..." | ||
Vol 18, No 1 (2022) | Aging Challenges. Perceived Age – a New Predictor of Longevity? | Abstract similar documents |
S. A. Shalnova, N. A. Imaeva, A. E. Imaeva, A. V. Kapustina | ||
"... identified risk factors that affect the facial skin, including smoking, systematic consumption of alcoholic ..." | ||
Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
A. V. Rudakova | ||
"... of any medical technology is economic value and cost-effectiveness. The objective of this review ..." | ||
Vol 11, No 3 (2015) | PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT | Abstract similar documents |
A. V. Rudakova | ||
"... or oral anticoagulants that differ significantly in their efficacy, safety and cost of the therapy. Aim ..." | ||
Vol 8, No 1 (2012) | PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION | Abstract similar documents |
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov | ||
"... the cost-effectiveness of dabigatran etexilate versus warfarin prescribed in “real-world” settings from ..." | ||
Vol 14, No 2 (2018) | PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov | ||
"... of treatment and clinical practice results was built. Cost-effectiveness analysis was done by comparing two ..." | ||
Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
"... the results of the lipid profile. To perform a pharmacoeconomic analysis and evaluate the “cost/effectiveness ..." | ||
Vol 17, No 1 (2021) | Optimization of the Statin Therapy Algorithm in Outpatient Practice: Adherence and Economic Benefits | Abstract similar documents |
S. A. Davitashvili, D. V. Nebieridze, N. M. Akhmedzhanov, A. S. Lishuta, A. S. Safaryan | ||
"... adherence, effects on surrogate and hard endpoints, and cost-effectiveness of the two statin regimens were ..." | ||
Vol 8, No 6 (2012) | ASSESSMENT OF DIABETES RISK IN MEN WITH DIFFERENT LEVELS OF CARDIOVASCULAR RISK | Abstract similar documents |
M. N. Kovrigina, M. N. Mamedov | ||
"... . Material and methods. Men (n=378) with one or more CV risk factors (hypertension of stage 1–3, smoking ..." | ||
Vol 16, No 3 (2020) | The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention | Abstract PDF (Eng) similar documents |
Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk | ||
"... after 3 months were: diabetes mellitus (p=0.007), smoking (p=0.01), dyslipidemia (p=0.001), stent length ..." | ||
Vol 16, No 3 (2020) | Possibilities of Pulse Wave Contour Analysis in Diagnostics of Early Vascular Aging | Abstract similar documents |
A. M. Tuktarov, A. E. Filippov, A. A. Obrezan, L. V. Kukol' | ||
"... , and smoking. Conclusion. PPG is a simple, fast, and informative method that allows to evaluate the parameters ..." | ||
Vol 14, No 4 (2018) | Differences in the Incidence of Major Risk Factors in Patients with Ischemic or Hemorrhagic Stroke in the Siberian Population | Abstract similar documents |
S. Yu. Nikulina, A. A. Chernova, D. A. Nikulin, V. A. Shulman, S. V. Prokopenko, I. M. Platunova, O. V. Marilovceva, I. I. Lebedeva, A. A. Semenchukov, D. A. Yakovleva, V. N. Maksimov, A. V. Kuskaeva | ||
"... among them. Smoking was found in 22 (78.6%) patients in this group. Conclusion. Improvement ..." | ||
Vol 14, No 5 (2018) | Short Term Comparison Between Safety and Efficacy of Rosuvastatin 40 mg and Atorvastatin 80 mg in Patients with Acute Coronary Syndrome | Abstract PDF (Eng) similar documents |
Sh. A. Mostafa, Kh. Elrabat, M. Mahrous, M. Kamal | ||
"... , smoking and obesity), echocardiography (end-diastolic volume, end-systolic volume and ejection fraction ..." | ||
Vol 15, No 5 (2019) | Association Between Lipoprotein(a) and Risk Factors of Atherosclerosis in Russian Population (Data of Observational ESSE-RF study) | Abstract PDF (Eng) similar documents |
S. A. Shalnova, M. V. Ezhov, V. A. Metelskaya, S. E. Evstifeeva, V. I. Tarasov, G. A. Muromtseva, Yu. A. Balanova, A. E. Imaeva, A. V. Kapustina, A. A. Shabunova, O. A. Belova, I. A. Trubacheva, A. Y. Efanov, Z. T. Astakhova, N. V. Kulakova, S. A. Boytsov, O. M. Drapkina | ||
"... mass index, waist circumference and smoking status. Conclusion. According to the ESSE-RF data ..." | ||
Vol 17, No 6 (2021) | Factors Determining the Three-Year Dynamics of Lipid Metabolism Indicators in Residents of a Large Industrial Region of Siberia | Abstract similar documents |
D. P. Tsygankova, E. D. Bazdyrev, E. V. Indukaeva, A. S. Agienko, O. V. Nakhratova, G. V. Artamonova, O. L. Barbarash | ||
"... , hypertension, smoking, alcohol consumption and an increase in the number of respondents taking lipid-lowering ..." | ||
Vol 20, No 2 (2024) | The relationship of arterial hypertension, elevated low-density lipoprotein cholesterol and their combination with the occurrence of new cases of cardiovascular diseases in men and women of working age | Abstract similar documents |
S. A. Shalnova, E. B. Yarovaya, V. A. Metelskaya, E. M. Filichkina, A. V. Kapustina, V. A. Kutsenko, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva, S. E. Evstifeeva, S. A. Maksimov, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, Yu. I. Grinshtein, R. A. Libis, O. P Rotar, I. A. Trubacheva, A. Yu. Efanov, S. S. Yakushin, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, A. O. Konradi, S. A. Boytsov, E. V Shlyakhto, O. M. Drapkina | ||
"... and preventive institutions (health facilities). Socio-demographic data (gender, age, education, wealth), smoking ..." | ||
Vol 13, No 4 (2017) | CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS | Abstract similar documents |
N. A. Karoli, A. P. Rebrov | ||
"... were associated with smoking status (r=0.61, p<0.01), severity of bronchial obstruction (r=-0.49, p<0 ..." | ||
Vol 4, No 5 (2008) | CARDIOVASCULAR RISK IN PATIENTS WITH ANKYLOSING SPONDYLITIS: THE ROLE OF SYSTEMIC INFLAMMATION AND ENDOTHELIAL DYSFUNCTION | Abstract similar documents |
D. A. Poddubnyy, A. P. Rebrov | ||
"... cardiovascular risk factors (smoking, hyper- and dislipoproteinemia, body overweight, heredity and diabetes ..." | ||
Vol 21, No 2 (2025) | Diagnostic performance of the 2019 ESC pre-test probability and Coronary Artery Disease consortium models in estimating obstructive coronary artery disease | Abstract similar documents |
Huy Truong Hoang, Dan Van Buu Do, Thao Le Phuong Nguyen, V. V. Maiskov, Z. D. Kobalava | ||
"... rates of male sex, hypertension, dyslipidemia, smoking, and typical and atypical angina (all p<0 ..." | ||
Vol 10, No 2 (2014) | PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM | Abstract PDF (Eng) similar documents |
A. M. Kalinina, A. V. Kontsevaya | ||
"... . Cost-effectiveness of primary prevention, including the one of MI, has been conclusively showed ..." | ||
Vol 13, No 5 (2017) | IS IT POSSIBLE TO IMPROVE THE ADHERENCE TO TREATMENT OF HYPERTENSION AND DYSLIPIDEMIA IN PATIENTS WITHOUT CLINICAL MANIFESTATIONS OF ATHEROSCLEROSIS? | Abstract similar documents |
A. А. Sarycheva, D. V. Nebieridze, T. V. Kamyshova | ||
"... in the case of achieving target levels of blood pressure (BP) and total cholesterol, smoking cessation ..." | ||
Vol 13, No 6 (2017) | HEART RATE AND ITS ASSOCIATION WITH THE MAIN RISK FACTORS IN THE POPULATION OF MEN AND WOMEN OF WORKING AGE | Abstract similar documents |
S. А. Shalnov, A. D. Deev, O. A. Belova, Yu. I. Grinshtein, D. V. Duplyakov, A. Yu. Efanov, E. V. Indukaeva, N. V. Kulakova, R. A. Libis, S. V. Nedogoda, O. P. Rotar, G. V. Tolparov, I. A. Trubacheva, T. M. Chernykh, A. A. Shabunova, S. A. Boytsov | ||
"... , elevated levels of blood pressure, triglycerides, glucose and CRP, but not education, smoking and alcohol ..." | ||
Vol 9, No 1 (2013) | OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS | Abstract PDF (Eng) similar documents |
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap | ||
"... .9%) patients. 770 (77%) patients were assessed on their total cholesterol level; smoking status and family ..." | ||
Vol 10, No 1 (2014) | MULTIFACTOR PRIMARY PREVENTION OF ISCHEMIC HEART DISEASE IN MIDDLE-AGED MEN AND ITS EFFICACY (10-YEAR FOLLOW-UP) | Abstract PDF (Eng) similar documents |
A. M. Kalinina | ||
"... , hypercholesterolemia, overweight, smoking, low physical activity) in the group 1 lasted for 5 years; the whole period ..." | ||
Vol 16, No 2 (2020) | Glomerular Filtration Rate, its Association with Risk Factors and Cardiovascular Diseases. The Results of the ESSE-RF-2 Study | Abstract similar documents |
S. A. Shalnova, S. A. Maksimov, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, V. I. Tarasov, I. A. Viktorova, A. N. Redko, N. N. Prishchepa, S. S. Yakushin, O. M. Drapkina | ||
"... .17), hyperuricemia (OR 1.51; 95%CI 1.39-1.63), no smoking (OR 0.79; 95%CI 0.73-0.85), history of kidney disease (OR 1 ..." | ||
Vol 18, No 1 (2022) | Three Year Prognosis of Patients with Myocardial Infarction Depending on the Body Weight Index: Data of the Kemerovo Acute Coronary Syndrome Registry | Abstract PDF (Eng) similar documents |
D. Yu. Sedykh, A. I. German, O. N. Hryachkova, V. V. Kashtalap, O. L. Barbarash | ||
"... was associated with: male, smoking, multivessel arterial diseases, non-endovascular reperfusion, acute HF with MI ..." | ||
Vol 17, No 5 (2021) | Social Network-Based Digital Stroke Prevention: Opportunities, Results and Prospects | Abstract PDF (Eng) similar documents |
A. E. Demkina, M. V. Bezzubtseva, M. N. Ryabinina, Ya. A. Kotlyar, O. L. Keln, А. V. Sarapulova, R. R. Zhetishev, V. S. Kuvaev, M. Y. Maksimova, N. V. Pogosova, I. V. Zhetisheva | ||
"... the following risk factors – smoking and other CVDs (p<0.05); stroke symptoms - headache and drooping ..." | ||
Vol 19, No 5 (2023) | Association of breast arterial calcification and carotid atherosclerosis as a marker of cardiovascular risk | Abstract similar documents |
E. V. Bochkareva, E. K. Butina, N. Kh. Bayramkulova, I. V. Kim, O. V. Molchanova, E. M. Filichkina, E. B. Yarovaya, V. A. Metelskaya, O. M. Drapkina | ||
"... levels, blood glucose, body mass index, incidence of hypertension, diabetes, or smoking. Women with BAC ..." | ||
Vol 20, No 1 (2024) | Study of the course of recurrent myocardial infarction in the acute stage within the framework the hospital register | Abstract similar documents |
S. Yu. Martsevich, A. V. Zagrebelnyy, O. S. Afonina, I. M. Kuzmina, Yu. V. Avdeev, N. A. Muradyan, O. M. Drapkina | ||
"... were significantly older, more often had a disability group. Smoking and arterial hypertension were ..." | ||
Vol 15, No 6 (2019) | Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up) | Abstract similar documents |
O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, I. V. Leontyeva, M. B. Kotova, E. I. Ivanova | ||
"... -aged men was made by TC and smoking. In the group with FH of CVD, higher stiffness of the arteries ..." | ||
Vol 16, No 1 (2020) | Cross-Sectional Study to Estimate the Prevalence of Familial Hypercholesterolemia in Selected Regions of the Russian Federation: Relevance, Design of the Study and Initial Characteristics of the Participants | Abstract similar documents |
A. N. Meshkov, A. I. Ershova, S. A. Shalnova, A. S. Alieva, S. S. Bazhan, O. L. Barbarash, D. Y. Bogdanov, I. A. Viktorova, Yu. I. Grinshtein, D. V. Duplyakov, O. N. Kalachikova, A. V. Kontsevaya, R. A. Libis, I. V. Medvedeva, V. A. Nevzorova, N. N. Prishchepa, O. P. Rotar, V. N. Serebryakova, I. A. Trubacheva, T. M. Chernykh, E. A. Shutemova, O. M. Drapkina, S. A. Boytsov | ||
"... , the following information is collected: age, sex, smoking status, presence of hypertension, history of coronary ..." | ||
Vol 16, No 2 (2020) | Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries | Abstract similar documents |
O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich | ||
"... is STEMI. The leading factors of cardiovascular risk in such patients are the male gender, active smoking ..." | ||
Vol 16, No 6 (2020) | Assessment of Subclinical Manifestations of Atherosclerosis of Coronary and Peripheral Arteries and Bone Strength Parameters in Women | Abstract PDF (Eng) similar documents |
I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, M. A. Myagkova, V. E. Novikov, O. Yu. Isaykina, O. M. Drapkina | ||
"... linear regression analysis (adjusted for age, menopause duration, low body weight, smoking factor ..." | ||
Vol 16, No 5 (2020) | Are Russian Men with Intermittent Claudication and/or Angina Pectoris Have the Same Cardiovascular and All-Cause Mortality Risks? The Data of the Prospective Population-Based Study | Abstract similar documents |
S. A. Shalnova, E. V. Yarovaya, Yu. K. Makarova, V. A. Kutsenko, A. V. Kapustina, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva | ||
"... significant contribution to mortality adjusted for high blood pressure, smoking, presence of ECG disturbances ..." | ||
Vol 14, No 5 (2018) | Basic Anthropometric Indices and Diabetes Mellitus Type 2 in Russian Population | Abstract similar documents |
O. M. Drapkina, R. N. Shepel, S. A. Shalnova, A. D. Deev, Yu. A. Balanova, S. E. Evstifeeva, Yu. V. Zhernakova, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, O. P. Rotar, E. V. Shlyakhto, S. A. Boytsov | ||
"... diabetes were analyzed: age; sex; anthropometric indicators: height, weight, WC; smoking status (“never ..." | ||
Vol 6, No 1 (2010) | THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE | Abstract similar documents |
Yu. V. Lukina, S. Yu. Martsevich | ||
"... ) are presented. Implementation of bisoprolol generics as well as bisoprolol usage in smoking cardiovascular ..." | ||
Vol 12, No 1 (2016) | Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease | Abstract similar documents |
E. I. Tarlovskaya, T. I. Chudinovskikh | ||
"... Aim. To compare the efficacy and cost/effectiveness ratio of the original and generic bisoprolol ..." | ||
Vol 16, No 1 (2020) | Association of the Level Healthcare Resource Consumption and Frequency of Temporary Disability Cases with Cardiovascular Risk Factors Based on Data of Population Study in Russian Federation | Abstract similar documents |
E. I. Suvorova, A. V. Kontsevaya, S. A. Shalnova, A. D. Deev, Yu. A. Balanova | ||
"... consumption and with hypercholesterolemia for men, and for women – in the smoking group, with obesity ..." | ||
Vol 16, No 1 (2020) | Thoracalgia in a Patient with Determined Coronary Heart Disease. Is there Always a Relapse of Angina Pectoris? | Abstract similar documents |
O. M. Drapkina, A. A. Zeynapur, A. S. Klevina, O. B. Vasileva | ||
"... disease and smoking, whose main complaint upon admission to the hospital was voice hoarseness and atypical ..." | ||
Vol 3, No 5 (2007) | RENAL HEMODYNAMICS AND GLOMERULAR FILTRATION RATE IN MEN AND WOMEN WITH ARTERIAL HYPERTENSION AT THE AGE OF 40-60 YEARS | Abstract similar documents |
I. G. Fomina, A. E. Bragina, N. E. Gaydamakina, J. N. Salimzhanova | ||
"... not differ in control group. Positive correlation r=0,61; p<0,05) between GGFR and a tobacco smoking ..." | ||
Vol 9, No 1 (2013) | PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review | Abstract similar documents |
T. S. Romanenko, A. V. Kontsevaya, S. V. Fitilev | ||
"... therapy, conducted during the last decades inRussia. Despite the increased interest to the issue of cost ..." | ||
1 - 100 of 148 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)